New research data provide additional support for CombiGene’s gene therapy for difficult-to-treat epilepsy

In epilepsy patients, drug-resistant seizures often occur in one of the temporal lobes.
The problematic area can, in some patients, be removed surgically, resulting in a
positive treatment outcome for the patient.


“This is an English translation of the Swedish website; if there is any inconsistency or ambiguity between the English version and the Swedish version, the Swedish version shall prevail. For a complete list of regulatory-related press releases, please refer to the Swedish website”